ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
6,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
7,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
8,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
10,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
11,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
11,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
11,5,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
11,6,Suprapubic pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
13,1,Breast disorder,Breast disorders NEC,Breast disorders,Repro,N
14,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
16,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
17,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Abdominal adhesions,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
18,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
18,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
19,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
19,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
20,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
20,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
22,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
24,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
25,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
26,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
27,1,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
27,2,Urinary sediment present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
28,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
28,2,Aortic arteriosclerosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
28,3,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
28,4,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
28,5,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
28,6,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
28,7,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
28,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
28,9,Pulmonary calcification,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
29,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
29,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
29,3,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
29,4,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
29,5,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
30,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
31,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
31,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
31,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
31,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
32,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
32,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
32,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
32,5,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
32,6,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
33,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
33,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
33,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
33,5,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
34,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
35,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
35,2,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
36,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
36,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
36,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
37,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
38,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
38,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
39,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
39,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
39,3,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
40,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
40,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
40,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
40,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
40,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
40,8,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
40,9,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
40,11,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
40,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
41,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
41,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
41,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
44,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
44,2,Hyperammonaemic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
45,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
45,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
45,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
47,1,Biopsy mucosa abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
47,2,Breath sounds abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
47,3,Bronchoscopy abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
47,4,Foreign body aspiration,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
47,5,Lower respiratory tract inflammation,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
47,6,Percussion test abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
47,7,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
47,8,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
47,9,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
47,10,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
47,11,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,12,Tracheal deviation,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
48,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
48,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
48,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
48,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
49,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
49,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
50,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
50,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
50,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
50,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
50,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
50,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
50,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
50,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
51,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
51,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
52,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
53,1,Biopsy bronchus abnormal,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
53,2,Bronchial aspiration procedure,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
53,3,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
54,1,Bronchial disorder,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
54,2,Foreign body aspiration,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
54,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
55,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
56,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
56,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
57,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
58,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
59,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
60,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
61,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
62,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
62,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,1,Biopsy colon abnormal,Gastrointestinal histopathology procedures,Gastrointestinal investigations,Inv,N
64,1,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
64,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
65,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
65,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
65,3,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
65,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
67,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
68,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
69,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
70,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
70,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
71,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
71,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
72,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
73,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
74,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
75,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
76,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
77,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
78,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
79,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
80,1,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
81,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
82,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
83,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
84,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
85,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
86,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
87,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
88,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
89,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
90,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
91,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
92,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
